{"id":"W2009325269","doi":"10.1089/aid.2006.0178","title":"Efficacy And Safety of Three Doses of Tipranavir Boosted with Ritonavir in Treatment-Experienced HIV Type 1-Infected Patients","year":2007,"lang":"en","type":"article","venue":"AIDS Research and Human Retroviruses","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Montreal Heart Institute","funders":"Boehringer Ingelheim","keywords":"Ritonavir; Medicine; Nausea; Adverse effect; Internal medicine; Vomiting; Gastroenterology; Pharmacokinetics; Viral load; Diarrhea; Protease inhibitor (pharmacology); Randomized controlled trial; Tolerability; Nelfinavir; Pharmacology; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003464485,0.0001787424,0.0004400566,0.0005303074,0.0001300408,0.00001390879,0.00006535246,0.00007755903,0.00006318345],"category_scores_gemma":[0.0001288991,0.000120717,0.00002634824,0.000596866,0.0005627148,0.00009953751,0.00005876195,0.0001529977,0.000004000392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001164787,"about_ca_system_score_gemma":0.00012697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000410079,"about_ca_topic_score_gemma":0.001004714,"domain_scores_codex":[0.9983644,0.00005949791,0.0003697411,0.0003025658,0.0004918626,0.0004118924],"domain_scores_gemma":[0.9988829,0.0003229303,0.00007615601,0.0002326134,0.0002947983,0.000190575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005064218,0.00115419,0.9807653,0.00006999684,0.0001476452,0.00004607779,0.001404518,8.599582e-8,0.003736464,0.0003586199,0.00003342296,0.007219453],"study_design_scores_gemma":[0.01080761,0.008660785,0.9611939,0.0002557975,0.0000377262,0.000003478959,0.0003805445,5.803746e-7,0.01796317,0.00004420748,0.0005459443,0.0001063289],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972018,0.000324012,0.000003562123,0.00003208991,0.00000917486,0.0007635706,0.00001524489,0.00001764127,0.001632928],"genre_scores_gemma":[0.9983804,0.0002213901,0.0003557403,0.000006249362,0.00001626131,0.00001429535,0.00006872613,0.00001861038,0.0009183636],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01957148,"threshold_uncertainty_score":0.4922698,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0563091343121845,"score_gpt":0.36558009969294,"score_spread":0.3092709653807555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}